Coherus BioSciences Inc. (CHRS)
NASDAQ: CHRS
· Real-Time Price · USD
1.05
0.03 (2.94%)
At close: Aug 15, 2025, 2:13 PM
Coherus BioSciences Revenue
Coherus BioSciences reported an annual revenue of $266.96M, reflecting a 3.78% growth. For the quarter ending June 30, 2025, Coherus BioSciences generated $10.25M in revenue.
Revenue (ttm)
266.96M
Revenue Growth
3.78%
Price / Sales Ratio
0.59
Revenue / Employee
1.17M
Employees
228
Market Cap
122.04M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|